Latest Period
Q2 2026
Security Snapshot
BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) Institutional Ownership
CUSIP: 10806X102
13F Institutional Holders and Ownership History from Q2 2019 to Q2 2026
Institutions Reporting
469
Shares (Excl. Options)
193,473,872
Price
$74.48
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- BBIO on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 193,473,872
- Total 13F value
- $14,401,991,508
- Portfolio coverage rank
- 0.02%
- Share change
- -1,268,251
- Value change
- -$95,305,143
- Number of holders
- 469
- Shares outstanding
- 196,441,255
- SEC-reported price per share
- $84.12
- Insider filing price
- $84.12
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 10806X102.
- 469 institutions reported positions in Q2 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 458 to 469 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $14,417,761,629 to $14,401,991,508.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 469 institutions filings for Q2 2026.
Security key
10806X102
Latest holder period
Q2 2026
13F holders
469
13D/G owners
7
CIK / CUSIP context first
Open Q2 2026 holders
BBIO full holder history
BridgeBio Pharma, Inc. SEC filings
BridgeBio Pharma, Inc. company facts
BridgeBio Pharma, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 10806X102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
BBIO
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 6.8% | +18% | $977,092,024 | +$161,518,142 | 13,179,013 | +20% | JANUS HENDERSON GROUP PLC | 31 Mar 2026 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 5.5% | $836,992,038 | 10,743,063 | Farallon Capital Management, L.L.C. | 30 Jun 2026 | |||
| Farallon Capital Partners, L.P. | 5.2% | $674,408,855 | 10,226,063 | Dapice Joshua J. | 22 May 2026 | |||
| VIKING GLOBAL INVESTORS LP | 5% | -18% | $729,325,450 | -$152,700,218 | 9,792,219 | -17% | VIKING GLOBAL INVESTORS LP | 09 Jul 2026 |
| BlackRock, Inc. | 5% | $724,970,594 | 9,733,762 | BlackRock, Inc. | 30 Jun 2026 | |||
| Kumar Neil | 4.6% | -16% | $689,354,243 | -$87,903,790 | 9,282,982 | -11% | NEIL KUMAR | 31 Mar 2026 |
| KKR Genetic Disorder L.P. | 4.7% | -33% | $719,322,695 | -$313,839,555 | 9,232,739 | -30% | KKR Group Partnership L.P. | 13 Aug 2026 |
As of 30 Jun 2026, 469 institutional investors reported holding 193,473,872 shares of BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO). This represents 98% of the company’s total 196,441,255 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
66%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 7.2% | 14,110,278 | 0% | 0.43% | $1,050,761,525 |
| Kohlberg Kravis Roberts & Co. L.P. | 6.8% | 13,260,971 | 0% | 17% | $987,677,120 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 5.5% | 10,743,063 | +15% | 4.7% | $800,143,332 |
| BlackRock, Inc. | 5.2% | 10,287,156 | -28% | 0.01% | $766,187,363 |
| VIKING GLOBAL INVESTORS LP | 5.1% | 9,949,219 | -16% | 2.1% | $741,017,831 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 7,898,973 | +1.8% | 0.01% | $588,315,509 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.9% | 7,656,722 | -5.2% | 0.03% | $570,272,655 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.7% | 5,308,924 | +114% | 0.07% | $395,408,660 |
| TWO SIGMA INVESTMENTS, LP | 2.4% | 4,722,185 | +51% | 0.26% | $351,708,339 |
| Aisling Capital Management LP | 2.3% | 4,589,611 | -9.8% | 72% | $341,834,227 |
| STATE STREET CORP | 2.3% | 4,435,932 | -10% | 0.01% | $330,388,215 |
| CITADEL ADVISORS LLC | 1.9% | 3,760,028 | +18% | 0.16% | $280,046,885 |
| Invesco Ltd. | 1.9% | 3,700,934 | -19% | 0.02% | $275,645,564 |
| D. E. Shaw & Co., Inc. | 1.8% | 3,633,007 | +43% | 0.17% | $270,586,362 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 3,418,419 | -30% | 0.01% | $254,669,075 |
| JANE STREET GROUP, LLC | 1.5% | 2,934,193 | +67% | 0.14% | $218,538,695 |
| JPMORGAN CHASE & CO | 1.2% | 2,397,995 | +83% | 0.01% | $173,229,954 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.1% | 2,252,000 | +276% | 0.24% | $167,728,960 |
| FRANKLIN RESOURCES INC | 1.1% | 2,160,173 | -11% | 0.03% | $160,889,674 |
| Polar Capital Holdings Plc | 1.1% | 2,063,609 | -18% | 0.44% | $153,697,598 |
| FMR LLC | 1% | 2,061,307 | -12% | 0.01% | $153,526,176 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 1% | 1,955,733 | -1.1% | 0.11% | $145,662,994 |
| SC US (TTGP), LTD. | 0.95% | 1,860,364 | 0% | 0.43% | $138,559,911 |
| GOLDMAN SACHS GROUP INC | 0.92% | 1,814,657 | -4.4% | 0.01% | $135,155,654 |
| UBS Group AG | 0.89% | 1,757,152 | -13% | 0.02% | $130,872,681 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
29
Latest
Q2 2026
Rows shown
1-25 of 29
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 193,473,872 | $14,401,991,508 | -$95,305,143 | $74.48 | 469 |
| 2026 Q1 | 194,117,298 | $14,417,761,629 | +$397,552,847 | $74.26 | 458 |
| 2025 Q4 | 188,214,200 | $14,404,286,659 | +$186,537,774 | $76.49 | 429 |
| 2025 Q3 | 184,963,434 | $9,606,937,258 | -$158,160,333 | $51.94 | 389 |
| 2025 Q2 | 188,818,044 | $8,154,464,813 | +$171,957,099 | $43.18 | 357 |
| 2025 Q1 | 185,173,982 | $6,405,659,483 | +$325,204,372 | $34.57 | 302 |
| 2024 Q4 | 176,645,317 | $4,847,193,349 | +$87,655,048 | $27.44 | 260 |
| 2024 Q3 | 172,596,886 | $4,393,814,683 | -$68,086,150 | $25.46 | 251 |
| 2024 Q2 | 174,953,530 | $4,431,556,073 | +$57,307,408 | $25.33 | 249 |
| 2024 Q1 | 171,539,419 | $5,303,582,949 | +$162,256,099 | $30.92 | 240 |
| 2023 Q4 | 165,715,337 | $6,690,573,516 | +$142,779,397 | $40.37 | 246 |
| 2023 Q3 | 161,102,840 | $4,243,730,776 | +$304,390,990 | $26.37 | 219 |
| 2023 Q2 | 149,815,028 | $2,576,329,186 | -$39,862,601 | $17.20 | 196 |
| 2023 Q1 | 152,372,388 | $2,526,139,807 | +$155,256,748 | $16.58 | 210 |
| 2022 Q4 | 144,623,389 | $1,101,997,850 | -$14,634,842 | $7.62 | 175 |
| 2022 Q3 | 145,248,661 | $1,443,911,522 | +$48,733,339 | $9.94 | 170 |
| 2022 Q2 | 140,449,294 | $1,275,283,327 | -$23,547,672 | $9.08 | 153 |
| 2022 Q1 | 143,303,557 | $1,454,787,082 | -$23,988,513 | $10.15 | 167 |
| 2021 Q4 | 141,976,495 | $2,367,117,577 | -$117,448,257 | $16.68 | 181 |
| 2021 Q3 | 140,028,398 | $6,563,888,337 | -$165,004,819 | $46.87 | 206 |
| 2021 Q2 | 142,676,491 | $8,697,122,835 | +$97,636,690 | $60.96 | 197 |
| 2021 Q1 | 141,085,070 | $8,688,930,801 | +$1,238,074,220 | $61.60 | 194 |
| 2020 Q4 | 121,079,579 | $8,609,553,572 | +$172,667,185 | $71.11 | 160 |
| 2020 Q3 | 117,841,767 | $4,393,419,330 | +$21,644,575 | $37.52 | 128 |
| 2020 Q2 | 117,300,177 | $3,824,660,106 | +$145,729,688 | $32.61 | 114 |